Reimagine Care Expands Clinical Advisory Board for Cancer Care Innovation

Reimagine Care, a leading provider of virtual-first cancer care, is excited to announce the growth of its Clinical Advisory Board. Renowned healthcare professionals specializing in cancer care have joined the board, bringing valuable expertise across the entire cancer spectrum. With a lineup of distinguished leaders, the board aims to offer strategic direction and insights to elevate Reimagine Care’s innovative solutions.

Led by Medical Director Dr. Pallav Mehta, Reimagine Care’s Clinical Advisory Board now encompasses a diverse array of experts spanning various oncology disciplines, including nursing, specialty medicine, policy, and health technology. Their collective wealth of experience is anticipated to steer Reimagine Care towards greater success in revolutionizing healthcare delivery and enhancing patient outcomes.

Dan Nardi, CEO of Reimagine Care, expressed excitement about the addition of these esteemed professionals to the Clinical Advisory Board, emphasizing their invaluable knowledge and experience in addressing the evolving needs of cancer patients and healthcare providers.

Dr. Pallav Mehta shared his enthusiasm for the diverse perspectives and skills each board member brings, highlighting their contributions to Reimagine Care’s strategic decision-making process and its leadership in virtual-first cancer care.

The Clinical Advisory Board comprises:

  • Dr. Yousuf Zafar, MD, MHS: A seasoned oncologist with extensive clinical, research, and healthcare administration background, focusing on optimizing patient outcomes while reducing healthcare costs.
  • Dr. Robert Hauser, PharmD, PhD: Co-Founder and Chief Business Development & Analytics Officer for Vidence, with over 25 years of experience in health economics, clinical trial development, and business development in the healthcare industry.
  • Shelley Fuld Nasso, MPP: Chief Executive Officer of the National Coalition for Cancer Survivorship (NCCS), bringing leadership in public policy and advocacy to improve cancer care delivery.

Shelley Fuld Nasso expressed her honor in joining Reimagine Care’s Clinical Advisory Board, emphasizing the importance of patient perspectives in revolutionizing patient care through technology and collaboration.

The expansion of the Clinical Advisory Board marks a significant milestone for Reimagine Care, positioning the company for continued growth and impact in healthcare. With the guidance of these esteemed healthcare leaders, Reimagine Care is primed to advance its mission of transforming the future of healthcare.

Source link

Newsletter Updates

Enter your email address below and subscribe to our newsletter